title: Perioperative acute kidney injury.
abstract: The incidence of acute kidney injury (AKI) is generally 5-7.5% in all acute care hospitalizations and accounts for up to 20% of admissions to intensive care units (ICUs). Of all of the cases of AKI during hospitalization, approximately 30-40% are observed in operative settings. AKI is a serious morbidity that is associated with greater length of hospital stay, high risk of hospital mortality, and increased risk of incident and progressive chronic kidney disease. The incidence of AKI is variable depending on the specific surgical setting under consideration. Much of our knowledge regarding the epidemiology of AKI is derived from studies related to cardiac or vascular surgery. With limited treatment options, prevention of AKI and amelioration of its severity remain important cornerstones of improving patient outcomes. The magnitude of the problem and the unique set of patient characteristics calls for a multidisciplinary approach for the perioperative management of renal complications. The purpose of the review presented here is to discuss the current knowledge regarding the epidemiology and risk factors, outcomes, diagnoses, and prevention and treatment of AKI during the perioperative period in cardiovascular and noncardiovascular surgical settings.
authors.affiliation: Section of Nephrology, Cincinnati VA Medical Center and University of Cincinnati, Cincinnati, OH 45267, USA. charuhas.thakar@uc.edu
authors.forename: Charuhas V
authors.initials: CV
authors.lastname: Thakar
mesh_terms: D058186:Acute Kidney Injury / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D015415:Biomarkers / Q000097:blood; D013504:Cardiovascular Surgical Procedures; D019610:Cytoprotection; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D007431:Intraoperative Complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D019990:Perioperative Care / Q000379:methods; D011183:Postoperative Complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011379:Prognosis; D020011:Protective Agents / Q000627:therapeutic use; D017582:Renal Replacement Therapy; D012307:Risk Factors; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D015415:Biomarkers; D004232:Diuretics; D020011:Protective Agents; D014665:Vasodilator Agents